In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel
Taking a daily multivitamin does not help people to live any longer and may actually increase...
